Area of research
Hepatology · Cancer Research
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Cancer, Hypoxia, and Metabolism, Cholangiocarcinoma and Gallbladder Cancer Studies, and Cancer, Lipids, and Metabolism.
Label-free tissue NIR-II autofluorescence imaging for visualization of human liver malignancy
Label-free tissue NIR-II autofluorescence imaging for visualization of human liver malignancy.
Prognostic and diagnostic value of [18F]FDG, 11C-acetate, and [68Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma
Transforming acidic coiled-coil-containing protein 3-mediated lipid metabolism reprogramming impairs CD8+ T-cell cytotoxicity in hepatocellular carcinoma
Tumour-associated macrophages serve as an acetate reservoir to drive hepatocellular carcinoma metastasis.
Comparison of <sup>11</sup>C-Acetate and <sup>18</sup>F-FDG PET/CT for Immune Infiltration and Prognosis in Hepatocellular Carcinoma.
Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives
Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma
Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma
Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils
Targeting SPP1-orchestrated neutrophil extracellular traps-dominant pre-metastatic niche reduced HCC lung metastasis
The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression
Emerging Regulatory Mechanisms of N<sup>6</sup>-Methyladenosine Modification in Cancer Metastasis.
Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
The combination of PD-1 blockade with interferon-α has a synergistic effect on hepatocellular carcinoma
Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3-ABCB1 Signaling in Hepatocellular Carcinoma.
Pan-Cancer Analysis Reveals a Distinct Neutrophil Extracellular Trap-Associated Regulatory Pattern
Biomarkers for response to immunotherapy in hepatobiliary malignancies
Current landscape and perspective of oncolytic viruses and their combination therapies
The critical function of metabolic reprogramming in cancer metastasis
A Prognostic Nomogram for Hepatocellular Carcinoma Based on Wound Healing and Immune Checkpoint Genes.
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives